Trial intelligence / Profile preview

Evaluation of Immune Response to Intradermal vs Intramuscular Inactivated Influenza Vaccine in Adults and Elderly

2007-002104-18Phase 2Completed

Sponsor
Sanofi
Start
Jul 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2 trial of Fluzone Intradermal in influenza (2 arms), sponsored by Sanofi. Primary endpoint: Cellular Immune Response. Started Jul 2007; status: completed.

02

Drugs

Fluzone Intradermal
03

Conditions

influenza

Beyond the preview

Go deeper on 2007-002104-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002104-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call